Recidiva postrasplante del carcinoma hepatocelular. ¿Pueden disminuir la recidiva tumoral los regímenes de inmunodepresión con m-TOR? / No disponible
Med. clín., Monogr
; 11(4): 24-28, abr. 2011. ilus, tab
Article
in Spanish
| IBECS
| ID: ibc-171969
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
No disponible
Search on Google
Collection:
National databases
/
Spain
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
IBECS
Main subject:
Recurrence
/
Carcinoma, Hepatocellular
/
Intercellular Signaling Peptides and Proteins
/
TOR Serine-Threonine Kinases
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Med. clín., Monogr
Year:
2011
Document type:
Article
Institution/Affiliation country:
Hospital General Universitario Gregorio Marañón/España